Navigation Links
Global Anesthesia Drugs Market 2012-2016 Reveals That One of the Major Challenges in this Market is the Presence of Several Regulations for Anesthesia Drugs
Date:12/13/2013

DUBLIN, December 13, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/t2t8pl/global_anesthesia) has announced the addition of the "Global Anesthesia Drugs Market 2012-2016" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

TechNavio's analysts forecast the Global Anesthesia Drugs market to grow at a CAGR of 2.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the number of emergency surgeries. The Global Anesthesia Drugs market has also been witnessing the pediatrics applications of anesthesia. However, the allergic reactions in anesthesia could pose a challenge to the growth of this market.

The key vendors dominating the Anesthesia Drugs market space are Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc.

The other vendors mentioned in the report are Celgene Corporation, Claris Life Sciences, Eisai Co. Ltd., Endo Pharmaceuticals Inc., Halocarbon Products Corp., Hospira Inc., Merck and Co., Piramal Healthcare, and Roche Diagnostics.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Earlier, vendors manufactured gender-neutral anesthesia drugs. Nowadays, sex-based anesthesia drugs are being introduced into the market to address the concerns related to perioperative anesthetic care for both sexes. This trend has a strong impact on the market.''

According to the report, one of the main drivers in this market is the increasing aging population across the world. The aging population across the world is expected to increase massively by 2050. This increase in the aging population results in increased surgeries, which in turn leads to increased use of anesthesia drugs. Thus, the growing aging population across the world propels the growth of the Global Anesthesia Drugs market.




For more information visit http://www.researchandmarkets.com/research/t2t8pl/global_anesthesia

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Digital Radiography - Global Strategic Business Report
2. Global HIV Infection Drug Pipeline Analysis
3. Equine Healthcare Market is Expected to Reach USD 24.5 Billion Globally in 2019: Transparency Market Research
4. CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
5. Global Radiation Detection, Monitoring & Safety Market Report 2013-2017
6. Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018
7. Wearable Medical Devices Market is Expected to Reach USD 5.8 Billion Globally in 2019: Transparency Market Research
8. Global Laparoscopic Devices Industry
9. Global Gelatin Industry
10. Global Carotenoids Industry
11. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at ... Oat is recognized globally as one of the healthiest cereals, XieQingkui, the founder of ... a move to sow the seed of good karma. Buddhism spirit featuring benevolence and ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, ... experience the freedom of recovery, they often feel shame for having struggled with an ... disorder (PTSD). In the workshop, “Rising Strong in Life After an Eating Disorder” -- ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body care ... announced the company had a successful visit to the 2017 ECRM Diet, Vitamin & ... that work in the nutritional, sports and health industries a chance to meet in ...
(Date:1/20/2017)... , ... January 20, 2017 , ... International Protein, a ... and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton Head, ... nutritional scientist who was determined to create a line of products that would elevate ...
(Date:1/20/2017)... ... , ... “The Angel”: a heartwarming and earnest tale of faith and ... children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional ... writer. , When asked of her new book, Marjorie says, “‘The Angel’ was written ...
Breaking Medicine News(10 mins):